| MeSH term | MeSH ID | Detail |
|---|---|---|
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Hyperlipidemias | D006949 | 73 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Seizures | D012640 | 87 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ford I et al. | Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. | 1993 | Br. J. Haematol. | pmid:8338784 |
| Cartwright IJ et al. | A haemorrhagic platelet disorder associated with altered stimulus-response coupling and abnormal membrane phospholipid composition. | 1994 | Br. J. Haematol. | pmid:7803235 |
| Coppola A et al. | Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. | 2005 | Br. J. Haematol. | pmid:16173969 |
| Sheu JR et al. | Mechanisms involved in the antiplatelet activity of magnesium in human platelets. | 2002 | Br. J. Haematol. | pmid:12472585 |
| Lages B and Weiss HJ | Heterogeneous defects of platelet secretion and responses to weak agonists in patients with bleeding disorders. | 1988 | Br. J. Haematol. | pmid:3345296 |
| Borowska A et al. | Impairment of primary haemostasis by low molecular weight heparins in rats. | 1988 | Br. J. Haematol. | pmid:3355792 |
| Dullemond-Westland AC et al. | Cryopreservation disturbs stimulus-response coupling in a platelet subpopulation. | 1987 | Br. J. Haematol. | pmid:3689695 |
| Eldor A et al. | A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. | 1999 | Br. J. Haematol. | pmid:10606878 |
| Defreyn G et al. | Familial bleeding tendency with partial platelet thromboxane synthetase deficiency: reorientation of cyclic endoperoxide metabolism. | 1981 | Br. J. Haematol. | pmid:6268139 |
| Lagarde M et al. | Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. | 1978 | Br. J. Haematol. | pmid:205238 |
| Hardisty RM et al. | A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium. | 1983 | Br. J. Haematol. | pmid:6830700 |
| Dubé JN et al. | Characterization of a partial prostaglandin endoperoxide H synthase-1 deficiency in a patient with a bleeding disorder. | 2001 | Br. J. Haematol. | pmid:11442478 |
| Hornby EJ et al. | Activation of human platelets by exposure to a monoclonal antibody, PM6/248, to glycoprotein IIb-IIIa. | 1991 | Br. J. Haematol. | pmid:1958486 |
| Bloom A et al. | Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis. | 1986 | Br. J. Haematol. | pmid:3080018 |
| Jackson CA et al. | Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. | 1982 | Br. J. Haematol. | pmid:6810912 |
| Faint RW et al. | Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro. | 1991 | Br. J. Haematol. | pmid:1851034 |
| Henry A et al. | Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein. | 1998 | Br. J. Haematol. | pmid:9827912 |
| Cunnane SC et al. | n-3 Essential fatty acids decrease weight gain in genetically obese mice. | 1986 | Br. J. Nutr. | pmid:3676212 |
| Aukema HM et al. | Dietary fish oil reduces glomerular injury and elevated renal hydroxyeicosatetraenoic acid levels in the JCR:LA-cp rat, a model of the metabolic syndrome. | 2013 | Br. J. Nutr. | pmid:23151363 |
| Chiu HF et al. | Mechanisms involved in the antiplatelet effect of C-phycocyanin. | 2006 | Br. J. Nutr. | pmid:16469164 |
| Luceri C et al. | p-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo. | 2007 | Br. J. Nutr. | pmid:17313706 |
| Coates AM et al. | Regular consumption of n-3 fatty acid-enriched pork modifies cardiovascular risk factors. | 2009 | Br. J. Nutr. | pmid:18590592 |
| Correa JA et al. | Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid. | 2009 | Br. J. Nutr. | pmid:18775097 |
| Sanders TA and Hochland MC | A comparison of the influence on plasma lipids and platelet function of supplements of omega 3 and omega 6 polyunsaturated fatty acids. | 1983 | Br. J. Nutr. | pmid:6639916 |
| Trefiletti G et al. | 1-Phenyl-6,7-dihydroxy-isochroman suppresses lipopolysaccharide-induced pro-inflammatory mediator production in human monocytes. | 2011 | Br. J. Nutr. | pmid:21269535 |
| Elliott GR et al. | The effect of acute feeding of carnitine, acetyl carnitine and propionyl carnitine on basal and A23187-stimulated eicosanoid release from rat carrageenan-elicited peritoneal macrophages. | 1990 | Br. J. Nutr. | pmid:2171633 |
| Berrougui H et al. | Argan (Argania spinosa) oil lowers blood pressure and improves endothelial dysfunction in spontaneously hypertensive rats. | 2004 | Br. J. Nutr. | pmid:15613254 |
| Canales A et al. | Platelet aggregation, eicosanoid production and thrombogenic ratio in individuals at high cardiovascular risk consuming meat enriched in walnut paste. A crossover, placebo-controlled study. | 2009 | Br. J. Nutr. | pmid:19068151 |
| Ren R et al. | Modulation of platelet aggregation-related eicosanoid production by dietary F-fucoidan from brown alga Laminaria japonica in human subjects. | 2013 | Br. J. Nutr. | pmid:23374164 |
| De La Cruz JP et al. | Virgin olive oil administration improves the effect of aspirin on retinal vascular pattern in experimental diabetes mellitus. | 2010 | Br. J. Nutr. | pmid:20350343 |
| D'Orléans-Juste P et al. | Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro. | 1991 | Br. J. Pharmacol. | pmid:1797310 |
| Landucci EC et al. | Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2. | 1995 | Br. J. Pharmacol. | pmid:7537590 |
| Esser R et al. | Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. | 2005 | Br. J. Pharmacol. | pmid:15655513 |
| Arimura A et al. | Contribution of thromboxane A2 to the antigen-induced immediate asthmatic response mediated by IgG1 antibody by augmentation of bronchial responsiveness in guinea-pigs. | 1994 | Br. J. Pharmacol. | pmid:7912155 |
| McMillan RM et al. | Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase. | 1992 | Br. J. Pharmacol. | pmid:1334748 |
| Goel RK et al. | Effect of ethanol on eicosanoid synthesis by human gastric and colonic mucosal pieces. | 1990 | Br. J. Pharmacol. | pmid:2328396 |
| Wainwright CL et al. | NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. | 2002 | Br. J. Pharmacol. | pmid:11959790 |
| Gallenkämper W et al. | Cardioprotective actions of pentoxifylline in an animal model of acute myocardial ischaemia. | 1984 | Br. J. Pharmacol. | pmid:6547067 |
| Anhut H et al. | Prostaglandin D2 is the prevailing prostaglandin in the acute inflammatory exudate of urate arthritis in the chicken. | 1979 | Br. J. Pharmacol. | pmid:570865 |
| Coker SJ and Parratt JR | The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion. | 1984 | Br. J. Pharmacol. | pmid:6547068 |
| Giembycz MA et al. | Leukotriene D4 receptors are not negatively coupled to adenylyl cyclase in guinea-pig lung parenchyma. | 1993 | Br. J. Pharmacol. | pmid:8385538 |
| Yin K et al. | Blood pressure and vascular reactivity changes in spontaneously hypertensive rats fed fish oil. | 1991 | Br. J. Pharmacol. | pmid:1855129 |
| Elliott GR et al. | Prostaglandin E2 inhibits and indomethacin and aspirin enhance, A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages. | 1989 | Br. J. Pharmacol. | pmid:2538186 |
| Davidson EM et al. | The release of thromboxane B2 by rabbit peritoneal polymorphonuclear leucocytes [proceedings]. | 1978 | Br. J. Pharmacol. | pmid:667479 |
| Panara MR et al. | Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. | 1995 | Br. J. Pharmacol. | pmid:8581280 |
| Renesto P et al. | Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine. | 1991 | Br. J. Pharmacol. | pmid:1653073 |
| Furman BL et al. | Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats. | 1984 | Br. J. Pharmacol. | pmid:6375795 |
| De La Cruz JP et al. | Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes. | 1999 | Br. J. Pharmacol. | pmid:10602334 |
| Ritter JM | Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor. | 1984 | Br. J. Pharmacol. | pmid:6386089 |
| Gordon D et al. | Selective inhibition of thromboxane biosynthesis in human blood mononuclear cells and the effects of mitogen-stimulated lymphocyte proliferation. | 1981 | Br. J. Pharmacol. | pmid:7317694 |
| Okamura T et al. | Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries. | 1988 | Br. J. Pharmacol. | pmid:3359109 |
| Dirig DM and Yaksh TL | In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin. | 1999 | Br. J. Pharmacol. | pmid:10217526 |
| Ochi T and Goto T | Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. | 2002 | Br. J. Pharmacol. | pmid:11834626 |
| Zingarelli B et al. | The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. | 1997 | Br. J. Pharmacol. | pmid:9031736 |
| Sheu JR et al. | Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. | 2004 | Br. J. Pharmacol. | pmid:15289295 |
| Giuliano F and Warner TD | Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. | 1999 | Br. J. Pharmacol. | pmid:10372826 |
| Moroney MA et al. | Differential regulation of 5-lipoxygenase and cyclo-oxygenase pathways of arachidonate metabolism in rat peritoneal leukocytes. | 1990 | Br. J. Pharmacol. | pmid:2178012 |
| Tateson JE et al. | Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. | 1988 | Br. J. Pharmacol. | pmid:2840160 |
| Tavares-Murta BM et al. | Interference of a neutrophil recruitment inhibitory factor upon the accumulation of inflammatory cells and airway hyperreactivity in sensitized guinea-pigs after intranasal antigen challenge. | 1993 | Br. J. Pharmacol. | pmid:7680596 |
| Flower RJ et al. | A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. | 1986 | Br. J. Pharmacol. | pmid:3006856 |
| Huntjens DR et al. | Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers. | 2006 | Br. J. Pharmacol. | pmid:16682968 |
| Minuz P et al. | NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes. | 2001 | Br. J. Pharmacol. | pmid:11606332 |
| Brunelleschi S et al. | Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins. | 1992 | Br. J. Pharmacol. | pmid:1281723 |
| Henrion D et al. | Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. | 1997 | Br. J. Pharmacol. | pmid:9146891 |
| Failli P et al. | Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. | 1998 | Br. J. Pharmacol. | pmid:9579743 |
| Franconi F et al. | Further insights into the anti-aggregating activity of NMDA in human platelets. | 1998 | Br. J. Pharmacol. | pmid:9630340 |
| Burka JF and Garland LG | A possible modulatory role for prostacyclin (PGI2) INIgGa-induced release of slow-reacting substance of anaphylaxis in rats. | 1977 | Br. J. Pharmacol. | pmid:339980 |
| Ambler J et al. | CGS 12970: a novel, long acting thromboxane synthetase inhibitor. | 1985 | Br. J. Pharmacol. | pmid:2932197 |
| Neupert W et al. | Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. | 1997 | Br. J. Pharmacol. | pmid:9351505 |
| Matz RL et al. | Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. | 2000 | Br. J. Pharmacol. | pmid:10991924 |
| Aehringhaus U et al. | Effect of inhibition of synthesis and receptor antagonism of SRS-A in cardiac anaphylaxis. | 1983 | Br. J. Pharmacol. | pmid:6689134 |
| Xu Y et al. | Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors. | 2009 | Br. J. Pharmacol. | pmid:19572944 |
| Zhao L et al. | Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor. | 2009 | Br. J. Pharmacol. | pmid:19220291 |
| Ziyyat A et al. | Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat. | 1996 | Br. J. Pharmacol. | pmid:8886425 |
| Booth RF et al. | Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo. | 1989 | Br. J. Pharmacol. | pmid:2522336 |
| Higgs GA et al. | The source of thromboxane and prostaglandins in experimental inflammation. | 1983 | Br. J. Pharmacol. | pmid:6652359 |
| Hay DW et al. | Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea. | 1993 | Br. J. Pharmacol. | pmid:7507780 |
| Rho MC et al. | Activation of rabbit platelets by Ca2+ influx and thromboxane A2 release in an external Ca(2+)-dependent manner by zooxanthellatoxin-A, a novel polyol. | 1995 | Br. J. Pharmacol. | pmid:7582454 |
| Frazer CE and Ritter JM | Recovery of prostacyclin synthesis by rabbit aortic endothelium and other tissues after inhibition by aspirin. | 1987 | Br. J. Pharmacol. | pmid:3297227 |
| Sakai H et al. | E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. | 2002 | Br. J. Pharmacol. | pmid:12023941 |
| Fujii Y and Sakurai J | Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism. | 1989 | Br. J. Pharmacol. | pmid:2497921 |
| Holgate ST and Robinson C | 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-Prostaglandin I1, (U-60,257) stimulates prostaglandin D2 and inhibits thromboxane B2 release from ionophore challenged human dispersed lung cells. | 1984 | Br. J. Pharmacol. | pmid:6439267 |
| Bult H et al. | Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. | 1985 | Br. J. Pharmacol. | pmid:3838489 |
| Sahota T et al. | Model-based prediction of the acute and long-term safety profile of naproxen in rats. | 2015 | Br. J. Pharmacol. | pmid:25884765 |
| Edwards JS and Ritter JM | Effect of cytoplasmic pH on Ca(2+)-stimulated eicosanoid biosynthesis in human platelets. | 1994 | Br. J. Pharmacol. | pmid:7858887 |
| Sheu JR et al. | The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase. | 1999 | Br. J. Pharmacol. | pmid:10455267 |
| Yin K et al. | Study of mechanisms of glucocorticoid hypertension in rats: endothelial related changes and their amelioration by dietary fish oils. | 1992 | Br. J. Pharmacol. | pmid:1393269 |
| Jiménez R et al. | Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta. | 1999 | Br. J. Pharmacol. | pmid:10455307 |
| Hatmi M et al. | Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics. | 1991 | Br. J. Pharmacol. | pmid:1665743 |
| Boukili MA et al. | Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade. | 1986 | Br. J. Pharmacol. | pmid:3096407 |
| Schuijt MP et al. | The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers. | 2009 | Br. J. Pharmacol. | pmid:19466986 |
| Krell RD and Kusner EJ | Differential effect of cyclo-oxygenase inhibition on antigen- and ionophore-induced release of slow reacting substance from fragmented guinea-pig lung. | 1984 | Br. J. Pharmacol. | pmid:6434013 |
| de Sotomayor MA et al. | Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. | 2005 | Br. J. Pharmacol. | pmid:16231003 |
| Chu ZM and Beilin LJ | Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric-oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats. | 1993 | Br. J. Pharmacol. | pmid:8358537 |
| Mallarkey G and Smith GM | A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats. | 1985 | Br. J. Pharmacol. | pmid:3156648 |
| Desquand S et al. | The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086. | 1990 | Br. J. Pharmacol. | pmid:2379029 |
| Riendeau D et al. | Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. | 1997 | Br. J. Pharmacol. | pmid:9146894 |
| Lefer AM et al. | Pathophysiological mechanisms of sudden death induced by platelet activating factor. | 1984 | Br. J. Pharmacol. | pmid:6435705 |
| Yeh CH et al. | Pharmacological characterization and antithrombotic effect of agkistin, a platelet glycoprotein Ib antagonist. | 2001 | Br. J. Pharmacol. | pmid:11181425 |
| Emms H and Lewis GP | The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat. | 1986 | Br. J. Pharmacol. | pmid:3082399 |